Could dropping one drug make stem cell transplants safer?
Disease control
Ongoing
This study looks at whether it is safe to remove one immune-suppressing drug, mycophenolate mofetil (MMF), from the standard treatment plan after a stem cell transplant for blood cancers. Sixty adults aged 18 to 75 will receive the transplant without MMF and be monitored for up t…
Phase: PHASE2 • Sponsor: Ronald Paquette • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC